The USF Diabetes and Endocrinology Center, as part of USF Health and Tampa General Hospital, is this region’s only academic medical center, provides a level of expertise that is unmatched in the Tampa Bay area.
We are this region’s epicenter for diabetes and endocrinology treatment, research, and education – offering a multidisciplinary team of providers who are specially trained to diagnose, treat, and engage with patients and their families to manage complex diabetes and endocrine disorders.
Tampa General Hospital Diabetes & Endocrinology is ranked #18 in the U.S. and #2 in Florida.
Our clinical team includes four pediatric and five adult board-certified endocrinologists, two adult endocrine nurse practitioners, a clinical social worker, a mental health therapist, and three registered dietitians as well as two diabetes educators specializing in diabetes technology training; working with a clinical support team to meet the needs of our patients. In addition to our multidisciplinary diabetes program, our providers care for a full spectrum of hormone-related conditions including bone and calcium, thyroid, growth, adrenal, pubertal, menopausal, and transgender concerns that may lead to, short stature, early or late puberty, atypical sexual development. pituitary disease, polycystic ovarian syndrome and infertility, and adrenal disorders.
Our center is recognized worldwide as a premier research center for diabetes. Our commitment to research is evidenced by our recognition as global leader in diabetes research. Our Center is funded by the National Institutes of Health as an affiliate of the Type 1 Diabetes TrialNet consortium and a Center for the Diabetes Interventions and Complications(EDIC) and Immune Tolerance DESIGNATE studies. We collaborate with academic and industry partners to advance therapies and technologies to better enable patients to manage their disease and to ultimately prevent and cure diabetes and related endocrine disorders.
USF Awarded Four-Year, $69.9 Million NIH Grant to Continue Type 1 Diabetes Research
The Environmental Determinants of Diabetes in the Young study is led by USF Health’s Jeffrey Krischer, who has built a worldwide epidemiological hub for T1D research at USF.
Click here to view full article.
Diabetes & COVID-19 Vaccine Access:
Contact Your Governor
States are rolling out their COVID-19 vaccination plans, and some states are not giving people with type 1 and type 2 diabetes equal access to the vaccine. Vaccination is an important tool to protect everyone with diabetes and end the pandemic, which clinical evidence has shown puts people with diabetes at increased risk for severe illness.
That's where ADA needs your voice: Will you ask your Governor to prioritize all people with diabetes for the vaccine?
Over 5,000 ADA Advocates have contacted their governors already, but we are going to need more people to break through. Join us today, and help spread the word by sharing this with your family, friends, and networks.
Making this change is time-sensitive, as states are now operationalizing vaccine rollouts.
Together, we'll keep working to ensure decision makers understand that people with diabetes have been disparately impacted by the pandemic and must be prioritized in vaccine distribution plans. Join us in contacting your governor today.
ADA Advocacy
P.S. Get the latest information on ADA's COVID-19 Hub and COVID-19 Vaccination Guide to keep yourself and others healthy.
Please also see these resources for keeping you kids safe at school during COVID-19.
